What are the recommendations for patients with pseudoexfoliation syndrome undergoing cataract surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Patients with pseudoexfoliation syndrome undergoing cataract surgery should be managed with a combination of pharmacologic dilation, careful surgical technique, and close postoperative monitoring to minimize the risk of complications, as recommended by the most recent study 1.

Preoperative Considerations

  • A thorough assessment of zonular weakness and pupillary dilation is essential before surgery.
  • Pharmacologic dilation using a combination of tropicamide 1%, phenylephrine 2.5%, and cyclopentolate 1% should be started 30-60 minutes before surgery.
  • For poor dilation, intracameral epinephrine (1:10,000) or phenylephrine can be used during surgery.

Intraoperative Considerations

  • Surgeons should plan for potential zonular instability by having capsular tension rings (CTRs) and iris hooks available.
  • A careful hydrodissection with minimal pressure, creation of a slightly larger capsulorhexis (5.5-6.0 mm), and gentle phacoemulsification with reduced fluidic parameters are recommended.
  • Capsular staining with trypan blue may improve visualization of the anterior capsule.
  • Intraocular lens selection should favor one-piece acrylic IOLs placed in the capsular bag when possible, with consideration of a CTR for moderate zonular weakness.

Postoperative Considerations

  • Patients require close monitoring for intraocular pressure spikes, inflammation, and late complications like IOL decentration or capsular phimosis.
  • A standard regimen of topical antibiotics for one week and steroids tapered over 3-4 weeks is typically prescribed, with potential addition of NSAIDs for inflammation control, as supported by the study 1 which found that routine cataract surgery of pseudoexfoliation eyes with nonsteroidal anti-inflammatory drugs (NSAID) alone, or in combination with steroids resulted in faster recovery from surgery and avoidance of pseudophakic cystoid macular edema (PCME) compared to steroids alone.
  • The use of NSAIDs, such as nepafenac, in combination with steroids, has been shown to reduce the risk of PCME and promote faster recovery from surgery 1.

Key Recommendations

  • Use of NSAIDs in combination with steroids for postoperative inflammation control 1.
  • Close monitoring for intraocular pressure spikes, inflammation, and late complications.
  • Careful surgical technique, including careful hydrodissection and gentle phacoemulsification.
  • Use of capsular tension rings and iris hooks for potential zonular instability.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.